| Stage | BKNG | % of rev | XPO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7.4B | 100.00% | $2.4B | 100.00% | BKNG ×3.10 |
| Gross profit | $7.4B | 100.00% | $973M | 41.00% | BKNG +59.0pp |
| Operating income | $2.5B | 34.00% | $288M | 12.14% | BKNG +21.9pp |
| Pre-tax income | $2.6B | 34.82% | $240M | 10.11% | BKNG +24.7pp |
| Net income | $1.9B | 26.52% | $181M | 7.63% | BKNG +18.9pp |
| Stage | BKNG | XPO | Gap · A − B |
|---|---|---|---|
| Revenue | $7.4B100.00% | $2.4B100.00% | BKNG ×3.10 |
| Gross profit | 100.00%$7.4B | 41.00%$973M | BKNG +59.0pp |
| Operating income | 34.00%$2.5B | 12.14%$288M | BKNG +21.9pp |
| Pre-tax income | 34.82%$2.6B | 10.11%$240M | BKNG +24.7pp |
| Net income |
| 26.52%$1.9B |
| 7.63%$181M |
| BKNG +18.9pp |
No shared counterparties.